Burden of smoking-related disease and potential impact of cigarette price increase in Peru

Hernandez-Vasquez, Akram (2016): Burden of smoking-related disease and potential impact of cigarette price increase in Peru. Published in: Rev Peru Med Exp Salud Publica , Vol. 4, No. 33 (19 December 2016): pp. 651-661.

Abstract

Objectives. To calculate the burden of smoking-related disease and evaluate the potential economic and health impact of tax-induced cigarette price increase in Peru. Materials and methods. A microsimulation model was used to estimate smoking-attributable impact on mortality, quality of life, and costs associated with heart and cerebrovascular disease, chronic obstructive pulmonary disease, pneumonia, lung cancer, and another nine cancers. Three scenarios, involving increased taxes, were evaluated. Results. A yearly total of 16,719 deaths, 6,926 cancer diagnoses, 7,936 strokes, and 7,548 hospital admissions due to cardiovascular disease can be attributed to smoking in Peru. Similarly, 396,069 years of life are lost each year from premature death and disability, and the cost of treating smoking-attributable health issues rises to 2,500 million soles (PEN 2015). Currently, taxes on tobacco cover only 9.1% of this expense. If cigarette prices were to increase by 50% over the next 10 years, 13,391 deaths, 6,210 cardiovascular events, and 5,361 new cancers could be prevented, representing an economic benefit of 3,145 million (PEN) in savings in health costs and increases in tax revenues. Conclusions. Smoking-attributable burden of disease and costs to the health system are very high in Peru. Higher cigarette taxes could have substantial health and economic benefits for the country.

• Item Type: MPRA Paper
• Language: Spanish
• Keywords: Health Economics, Tobacco use, Cost of illness, Cost-Benefit analysis Taxes, Peru
• Subjects: H - Public Economics > H2 - Taxation, Subsidies, and Revenue; I - Health, Education, and Welfare > I1 - Health; I - Health, Education, and Welfare > I1 - Health > I18 - Government Policy ; Regulation ; Public Health

References

Bundhamcharoen, K., Aungkulanon, S., Makka, N., & Shibuya, K. (2015). Economic burden from smoking-related diseases in Thailand. Tob Control. doi: 10.1136/tobaccocontrol-2015-052319

Caccavo A, Alvarez A, Bello F, et al. Incidencia poblacional del infarto con elevación del segmento ST o bloqueo de rama izquierda a lo largo de 11 años en una comunidad de la provincia de Buenos Aires. Rev Argent Cardiol 2007;75:185-8.

Ciapponi A, Bardach A, Casetta B, Aruj P, Linetzky B, Glujovsky D, & Mazzoni A. (2010). Tobacco Free Initiative. Systematic review of the link between tobacco and poverty. Research commissioned for WHO by the Institute for Clinical Effectiveness and Health Policy (Instituto de Efectividad Clínica y Sanitaria -IECS), Argentine Cochrane Centre IECS, Iberoamerican Cochrane Network. WHO Library Cataloguing-in-Publication Data; 2011 [citado el 2 de febrero de 2015]. Disponible en: http://www.who.int/tobacco/publications/syst_rev_tobacco_poverty/en/index.html.

Chaloupka, F., Hu, T.-W., Warner, K., Jacobs, R., & Yurekli, A. The taxation of tobacco products. In: Tobacco control in developing countries [Internet]. Oxford: Oxford University Press; 2000. Disponible en: http://catalogue.polytechnique.fr/site.php?id=298&fileid=4705. In P. Jha & F. Chaloupka (Eds.).

Chaloupka, F. J., Yurekli, A., & Fong, G. T. (2012). Tobacco taxes as a tobacco control strategy. Tob Control, 21(2), 172-180. doi: 10.1136/tobaccocontrol-2011-050417

Chávez Rodas V, Tapia Cabanillas L, Rojas Valero M, Zavaleta Martinez-Vargas A. Epidemiología de Drogas en la población urbana peruana 2010. Encuesta de Hogares. Monografía de investigación Nro 26. Centro de información y educación para la prevención del abuso de Drogas. Lima, Perú; 2011.

Dan, Y. Y., So, J. B., & Yeoh, K. G. (2006). Endoscopic screening for gastric cancer. Clin Gastroenterol Hepatol, 4(6), 709-716. doi: 10.1016/j.cgh.2006.03.025

Dirección General de Epidemiología. Carga de enfermedad en el Perú. Estimación de los años de vida saludables perdidos 2012 [Internet]. Lima: Ministerio de Salud; 2014 [citado el 15 de enero de 2016]. Disponible en: http://www.dge.gob.pe/portal/docs/tools/Cargaenfermedad2012.pdf.

Dirección General de Epidemiología. Epidemiología del consumo de tabaco en el Perú. Boletin Epidemiológico (Lima) 23(2) [Internet]. Lima: Ministerio de Salud; 2014 [citado el 25 de enero del 2016]. Disponible en: http://www.dge.gob.pe/portal/docs/vigilancia/boletines/2014/02.pdf

Doll, R., Peto, R., Boreham, J., & Sutherland, I. (2004). Mortality in relation to smoking: 50 years' observations on male British doctors. Bmj, 328(7455), 1519. doi: 10.1136/bmj.38142.554479.AE

Downer, M. C., Jullien, J. A., & Speight, P. M. (1997). An interim determination of health gain from oral cancer and precancer screening: 1. Obtaining health state utilities. Community Dent Health, 14(3), 139-142.

Ekpu, V. U., & Brown, A. K. (2015). The Economic Impact of Smoking and of Reducing Smoking Prevalence: Review of Evidence. Tob Use Insights, 8, 1-35. doi: 10.4137/tui.s15628

Estimaciones y proyecciones de población, 1950-2050 [Internet]. Lima: Instituto Nacional de Estadística e Informática; 2001 [citado el 15 de febrero de 2015]. Disponible en http://www.inei.gob.pe/media/MenuRecursivo/publicaciones_digitales/Est/Lib0466/Libro.pdf.

Gordois, A., Scuffham, P., Warren, E., & Ward, S. (2003). Cost-utility analysis of imatinib mesilate for the treatment of advanced stage chronic myeloid leukaemia. Br J Cancer, 89(4), 634-640. doi: 10.1038/sj.bjc.6601151

Graham, A. J., Shrive, F. M., Ghali, W. A., Manns, B. J., Grondin, S. C., Finley, R. J., & Clifton, J. (2007). Defining the optimal treatment of locally advanced esophageal cancer: a systematic review and decision analysis. Ann Thorac Surg, 83(4), 1257-1264. doi: 10.1016/j.athoracsur.2006.11.061

Guindon, G. E., Paraje, G. R., & Chaloupka, F. J. (2015). The impact of prices and taxes on the use of tobacco products in Latin America and the Caribbean. Am J Public Health, 105(3), e9-19. doi: 10.2105/ajph.2014.302396

Guindon, G. E., Tobin, S., & Yach, D. (2002). Trends and affordability of cigarette prices: ample room for tax increases and related health gains. Tob Control, 11(1), 35-43.

Hamel, M. B., Phillips, R. S., Davis, R. B., Teno, J., Connors, A. F., Desbiens, N., . . . Tsevat, J. (2000). Outcomes and cost-effectiveness of ventilator support and aggressive care for patients with acute respiratory failure due to pneumonia or acute respiratory distress syndrome. Am J Med, 109(8), 614-620.

Heinzer, H., Mir, T. S., Huland, E., & Huland, H. (1999). Subjective and objective prospective, long-term analysis of quality of life during inhaled interleukin-2 immunotherapy. J Clin Oncol, 17(11), 3612-3620.

Hoffman, S. J., & Tan, C. (2015). Overview of systematic reviews on the health-related effects of government tobacco control policies. BMC Public Health, 15, 744. doi: 10.1186/s12889-015-2041-6

Jiménez-Corona, A., López-Ridaura, R., & González-Villalpando, C. (2009). Incidence of myocardial infarction in low-income urban residents of Mexico City. Salud Pública de México, 51, 458-464.

Kirchhoff, M., Davidsen, M., Bronnum-Hansen, H., Hansen, B., Schnack, H., Eriksen, L. S., . . . Schroll, M. (1999). Incidence of myocardial infarction in the Danish MONICA population 1982-1991. Int J Epidemiol, 28(2), 211-218.

Kostova, D. (2013). A (nearly) global look at the dynamics of youth smoking initiation and cessation: the role of cigarette prices. Applied Economics, 45(28), 3943-3951. doi: 10.1080/00036846.2012.736947

Lightwood J, Lapsley H, & Novotny T. (2000). Estimating the costs of tobacco use. In Jha P & Chaloupka F (Eds.), Tobacco control in developing countries. (pp. 63-99). Oxford: Oxford University Press.

Lim, S. S., Vos, T., Flaxman, A. D., Danaei, G., Shibuya, K., Adair-Rohani, H., . . . Memish, Z. A. (2012). A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet, 380(9859), 2224-2260. doi: 10.1016/S0140-6736(12)61766-8

Main, C., Palmer, S., Griffin, S., Jones, L., Orton, V., Sculpher, M., . . . Riemsma, R. (2004). Clopidogrel used in combination with aspirin compared with aspirin alone in the treatment of non-ST-segment-elevation acute coronary syndromes: a systematic review and economic evaluation. Health Technol Assess, 8(40), iii-iv, xv-xvi, 1-141.

Martinez, E., Mejia, R., & Perez-Stable, E. J. (2015). An empirical analysis of cigarette demand in Argentina. Tob Control, 24(1), 89-93. doi: 10.1136/tobaccocontrol-2012-050711

McLean, S., Barbour, V., Wild, S., Simpson, C., & Sheikh, A. (2015). Models for estimating projections for disease prevalence and burden: a systematic review focusing on chronic obstructive pulmonary disease. J Health Serv Res Policy, 20(4), 246-253. doi: 10.1177/1355819615579232

Menezes, A. M., Perez-Padilla, R., Jardim, J. R., Muino, A., Lopez, M. V., Valdivia, G., . . . Victora, C. G. (2005). Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study. Lancet, 366(9500), 1875-1881. doi: 10.1016/s0140-6736(05)67632-5

Montazeri, A., Gillis, C. R., & McEwen, J. (1998). Quality of life in patients with lung cancer: a review of literature from 1970 to 1995. Chest, 113(2), 467-481.

Nease, R. F., Jr., Kneeland, T., O'Connor, G. T., Sumner, W., Lumpkins, C., Shaw, L., . . . Sox, H. C. (1995). Variation in patient utilities for outcomes of the management of chronic stable angina. Implications for clinical practice guidelines. Ischemic Heart Disease Patient Outcomes Research Team. Jama, 273(15), 1185-1190.

Oficina General de Estadística e Informática [Internet]. Lima: Ministerio de Salud; 2010 [citado el 20 de febrero 2015]. http://www.minsa.gob.pe/portada/estadistica/publicaciones.htm.

Pepper, P. V., & Owens, D. K. (2002). Cost-effectiveness of the pneumococcal vaccine in healthy younger adults. Med Decis Making, 22(5 Suppl), S45-57.

Pichon-Riviere A, Alcaraz A, Bardach A, Augustovski F, Caporale J, & Caccavo Francisco. Carga de Enfermedad atribuible al Tabaquismo en Argentina. Documento Técnico IECS N° 7 [Internet]. Buenos Aires, Argentina: Instituto de Efectividad Clínica y Sanitaria; 2013 [citado el 25 de enero de 2016]. Disponible en: http://www.iecs.org.ar/publicacion/?id=5471.

Pichon-Riviere A, Reynales-Shigematsu LM, Bardach A, Caporale J, Augustovski F, Alcaraz A, . . . E., H.-S. R. Carga de Enfermedad Atribuible al Tabaquismo en México. Documento Técnico IECS N° 10 [Internet]. Buenos Aires, Argentina: Instituto de Efectividad Clínica y Sanitaria; 2013 [citado el 25 de enero de 2016]. Disponible en: http://www.iecs.org.ar/publicacion/?id=5473.

Pichon-Riviere, A., Augustovski, F., Bardach, A., & Colantonio, L. (2011). Development and validation of a microsimulation economic model to evaluate the disease burden associated with smoking and the cost-effectiveness of tobacco control interventions in Latin America. Value Health, 14(5 Suppl 1), S51-59. doi: 10.1016/j.jval.2011.05.010

Pichón Riviere A, Bardach A, Caporale J, Alcaraz A, Augustovski F, Caccavo F, . . . Castillo Laborde C. Carga de Enfermedad atribuible al Tabaquismo en Chile. Documento Técnico IECS N° 8 [Internet]. Buenos Aires, Argentina: Instituto de Efectividad Clínica y Sanitaria; 2014 [citado el 25 de enero de 2016]. Disponible en: http://www.iecs.org.ar/publicacion/?id=5472.

Pinto, M. T., Pichon-Riviere, A., & Bardach, A. (2015). The burden of smoking-related diseases in Brazil: mortality, morbidity and costs. Cad Saude Publica, 31(6), 1283-1297. doi: 10.1590/0102-311x00192013

Rutten-van Molken, M., & Lee, T. A. (2006). Economic modeling in chronic obstructive pulmonary disease. Proc Am Thorac Soc, 3(7), 630-634. doi: 10.1513/pats.200603-095SS

Shenfine, J., McNamee, P., Steen, N., Bond, J., & Griffin, S. M. (2005). A pragmatic randomised controlled trial of the cost-effectiveness of palliative therapies for patients with inoperable oesophageal cancer. Health Technol Assess, 9(5), iii, 1-121.

Smoking-attributable mortality, years of potential life lost, and productivity losses. United States, 2000-2004. (2008). MMWR Morb Mortal Wkly Rep, 57(45), 1226-1228.

Tauras, J. A., & Chaloupka, F. J. (The demand for nicotine replacement therapies [Internet]. United States. National Bureau of Economic Research; 2001 [citado el 15 de febrero de 2016]. Disponible en: http://www.nber.org/papers/w8332 NBER working paper series no. 8332, (pp. 22 p.). doi:10.3386/w8332

Tengs, T. O., Yu, M., & Luistro, E. (2001). Health-related quality of life after stroke a comprehensive review. Stroke, 32(4), 964-972.

Thorvaldsen, P., Asplund, K., Kuulasmaa, K., Rajakangas, A. M., & Schroll, M. (1995). Stroke incidence, case fatality, and mortality in the WHO MONICA project. World Health Organization Monitoring Trends and Determinants in Cardiovascular Disease. Stroke, 26(3), 361-367.

Weygandt, P. L., Vidal-Cardenas, E., Gilman, R. H., Avila-Tang, E., Cabrera, L., & Checkley, W. (2012). Epidemiology of tobacco use and dependence in adults in a poor peri-urban community in Lima, Peru. BMC Pulm Med, 12, 9. doi: 10.1186/1471-2466-12-9

World Development Indicators, Data [Internet]. The World Bank; 2015. [citado el 13 de noviembre de 2015]. Disponible en: http://data.worldbank.org/data-catalog/world-development-indicators.

World Health Organization. International Agency for Research on Cancer. GLOBOCAN 2012. Estimated Cancer Incidence, Mortality and Prevalence Worldwide in 2012. Disponible en: http://globocan.iarc.fr/Pages/burden_sel.aspx. [citado el 20 de enero 2016].